
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | 2026-04-23 | JOBSON CHARLES E | 10% Owner | Purchase | 509 | $8.58 | $4K | 1.65M | View ↗ | |
| 2026-02-12 | 2026-02-17 | JOBSON CHARLES E | 10% Owner | Purchase | 15.4K | $8.50 | $131K | 1.65M | View ↗ | |
| 2026-02-11 | 2026-02-13 | JOBSON CHARLES E | 10% Owner | Purchase | 448 | $8.70 | $4K | 1.64M | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total revenues | $1.8M-14.9% | $2.2M+41.1% | $1.5M+5.2% | $1.5M |
| Total cost of revenues | $11.2M-2.5% | $11.5M+9.9% | $10.5M+14.3% | $9.2M |
| Selling and marketing expenses | $13.3M+21.2% | $11.0M+26.3% | $8.7M-37.8% | $14.0M |
| Depreciation and amortization | $1.6M+19.9% | $1.4M+7.3% | $1.3M-80.8% | $6.6M |
| General and administrative expenses | $29.6M-1.6% | $30.1M+14.8% | $26.2M-62.7% | $70.2M |
| Total selling, general and administrative expenses | $44.6M+5.0% | $42.5M+17.3% | $36.2M-60.2% | $90.8M |
| Net loss on disposition or impairment | $8K-88.0% | $66K | — | $410K |
| Loss from continuing operations | -$913K+51.6% | -$1.9M | — | — |
| Other income, net | $684K+144.0% | $280K | — | — |
| Loss from continuing operations before income tax expense | -$230K+85.7% | -$1.6M | — | — |
| Income tax expense | $39K+589.5% | $6K-99.9% | $11.0M+16004.8% | $68K |
| Net loss from continuing operations | -$268K+83.4% | -$1.6M | — | — |
| Income (loss) from discontinued operations before income tax expense | $3.2M+180.6% | -$4.0M | — | — |
| Income tax expense from discontinued operations | $25K-88.0% | $210K-42.8% | $368K | — |
| Net income (loss) from discontinued operations | $3.2M+175.9% | -$4.2M | — | — |
| Net income (loss) | $2.9M+150.2% | -$5.8M+40.6% | -$9.8M | — |
| Basic (in dollars per share) | $0.21+175.0% | -$0.28-500.0% | $0.07 | — |
| Diluted (in dollars per share) | $0.21+175.0% | -$0.28-500.0% | $0.07 | — |
| Basic (in dollars per share) | $0.21+175.0% | -$0.28-500.0% | $0.07 | — |
| Diluted (in dollars per share) | $0.21+175.0% | -$0.28-500.0% | $0.07 | — |
| Net income (loss) per common share, basic (in dollars per share) | $0.19+148.7% | -$0.39 | — | — |
| Net income (loss) per common share, diluted (in dollars per share) | $0.19+150.0% | -$0.38 | — | — |
| Basic weighted average shares outstanding (in shares) | $15.1M+1.4% | $14.9M | — | — |
| Diluted weighted average shares outstanding (in shares) | $15.2M+0.3% | $15.1M | — | — |
| Royalty fees | ||||
| Total revenues | $1.8M-14.9% | $2.2M+41.1% | $1.5M+5.2% | $1.5M |
| Franchise fees | ||||
| Total revenues | $1.8M-14.9% | $2.2M+41.1% | $1.5M+5.2% | $1.5M |
| Cost of revenues | $1.7M+18.7% | $1.5M+2.5% | $1.4M+3.6% | $1.4M |
| Advertising fund revenue | ||||
| Total revenues | $1.8M-14.9% | $2.2M+41.1% | $1.5M+5.2% | $1.5M |
| Software fees | ||||
| Total revenues | $1.8M-14.9% | $2.2M+41.1% | $1.5M+5.2% | $1.5M |
| Cost of revenues | $1.7M+18.7% | $1.5M+2.5% | $1.4M+3.6% | $1.4M |
| Other revenues | ||||
| Total revenues | $1.8M-14.9% | $2.2M+41.1% | $1.5M+5.2% | $1.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Joint Q1 2026 Earnings Preview
The Joint to sell 45 clinics for $2.3M; shifts to franchise-only model
The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California
The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast